Related Experiment Videos
Zucker obese rats store less acyl-estrone than lean controls
R M Massanés1, M M Grasa, J López-Martí
1Centre de Recerca en Nutrició i Cièncias dels Aliments, Facultat de Biologia, Universitat de Barcelona, Spain.
Summary
Obese rats, like humans, show lower circulating acyl-estrone levels than expected for their body fat. Pharmacological doses of oleoyl-estrone do not lead to estrone accumulation, indicating safety.
Area of Science:
- Endocrinology
- Metabolic Research
- Obesity Studies
Background:
- Acyl-estrone, a key hormone, plays a role in metabolic regulation.
- Obesity in humans is sometimes associated with lower circulating acyl-estrone levels.
- Investigating this link in animal models can provide insights into human obesity.
Purpose of the Study:
- To quantify acyl-estrone levels in Zucker obese rats.
- To explore the relationship between body fat and acyl-estrone in lean and obese rats.
- To assess the effect of oral oleoyl-estrone on estrone accumulation.
Main Methods:
- Measurements of circulating acyl-estrone and body lipids in Wistar, Goto-Kakizaki, and Zucker rats (lean and obese).
- Analysis of total body estrone and lipid ratios.
- Administration of varying oral doses of oleoyl-estrone to Wistar rats to track estrone intake, accrual, and excretion.
Main Results:
- A direct correlation between body lipid content and circulating acyl-estrone was observed in lean rats but not in Zucker obese rats.
- Obese rats exhibited significantly lower estrone/lipid mass ratios compared to lean rats.
- Wistar rats treated with oleoyl-estrone excreted most of the ingested compound, with no significant estrone accumulation.
Conclusions:
- Oral administration of acyl-estrone is safe in rats, as it does not lead to significant estrone accumulation.
- Obese rats display a similar pattern to humans, with lower circulating acyl-estrone levels relative to their body fat.
- Obesity in rats is associated with lower total body estrone content, suggesting a potential estrone deficiency.